GoldPWDrevetsWCCharneyDS. New insight into the role of cortisol and the glucocorticoid receptors in severe depression. Biol Psychiatry2002;52:381–5.
2.
SherLMannJJ. Psychiatric pathophysiology: Mood disorders. In: TasmanAKayJLiebermanJA, editors. Psychiatry. Chichester (UK): John Wiley & Sons, 2003, p 300–15.
3.
ShelineYIGadoMHKraemerHC. Untreated depression and hippocampal volume loss. Am J Psychiatry2003;160:1516–8.
4.
ShelineYI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry2003;54:338–52.
5.
DrevetsWCPriceJLSimpsonJRToddRDReichTVannierM, and others. Subgenual prefrontal cortex abnormalities in mood disorders. Nature1997;386:824–7.
6.
McEwenBSSapolskyRM. Stress and cognitive function. Curr Opin Neurobiol1995;5:205–16.
7.
SherLOquendoMAGalfalvyHCCooperTBMannJJ. Age effects on cortisol levels in depressed patients with and without a history of posttraumatic stress disorder, and healthy volunteers. J Affect Disord. Forthcoming.
8.
MacQueenGMCampbellSMcEwenBSMacdonaldKAmanoSJoffeRT, and others. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA2003;100:1387–92.
9.
SegalZVPearsonJLThaseME. Challenges in preventing relapse in major depression. Report of a National Institute of Mental Health workshop on state of the science of relapse prevention in major depression. J Affect Disord2003;77:97–108.
10.
TeasdaleJDSegalZVWilliamsJMRidgewayVASoulsbyJMLauMA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol2000;68:615–23.